Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Fenfluramine and methylphenidate in children with mental retardation and ADHD: clinical and side effects.

Aman MG, Kern RA, McGhee DE, Arnold LE.

J Am Acad Child Adolesc Psychiatry. 1993 Jul;32(4):851-9.

PMID:
8340309
2.

Fenfluramine and methylphenidate in children with mental retardation and borderline IQ: clinical effects.

Aman MG, Kern RA, Osborne P, Tumuluru R, Rojahn J, del Medico V.

Am J Ment Retard. 1997 Mar;101(5):521-34.

PMID:
9083608
3.
4.

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.

Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH.

Pediatrics. 2003 Nov;112(5):e404.

PMID:
14595084
6.

Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder.

Handen BL, Johnson CR, Lubetsky M.

J Autism Dev Disord. 2000 Jun;30(3):245-55.

PMID:
11055460
7.

Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD.

Handen BL, Feldman HM, Lurier A, Murray PJ.

J Am Acad Child Adolesc Psychiatry. 1999 Jul;38(7):805-12.

PMID:
10405497
8.

A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.

Pelham WE, Aronoff HR, Midlam JK, Shapiro CJ, Gnagy EM, Chronis AM, Onyango AN, Forehand G, Nguyen A, Waxmonsky J.

Pediatrics. 1999 Apr;103(4):e43.

PMID:
10103335
9.

Clinical effects of methylphenidate and thioridazine in intellectually subaverage children.

Aman MG, Marks RE, Turbott SH, Wilsher CP, Merry SN.

J Am Acad Child Adolesc Psychiatry. 1991 Mar;30(2):246-56.

PMID:
2016229
10.

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.

Research Units on Pediatric Psychopharmacology Autism Network.

Arch Gen Psychiatry. 2005 Nov;62(11):1266-74.

PMID:
16275814
11.

Efficacy of osmotic-release oral system (OROS) methylphenidate for mothers with attention-deficit/hyperactivity disorder (ADHD): preliminary report of effects on ADHD symptoms and parenting.

Chronis-Tuscano A, Seymour KE, Stein MA, Jones HA, Jiles CD, Rooney ME, Conlon CJ, Efron LA, Wagner SA, Pian J, Robb AS.

J Clin Psychiatry. 2008 Dec;69(12):1938-47. Epub 2008 Dec 2.

PMID:
19192455
12.

A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder.

Greenhill LL, Findling RL, Swanson JM; ADHD Study Group.

Pediatrics. 2002 Mar;109(3):E39.

PMID:
11875167
13.

Four-year follow-up of children with low intelligence and ADHD.

Aman MG, Pejeau C, Osborne P, Rojahn J, Handen B.

Res Dev Disabil. 1996 Nov-Dec;17(6):417-32.

PMID:
8946568
14.

Effects and noneffects of methylphenidate in children with mental retardation and ADHD.

Handen BL, Breaux AM, Janosky J, McAuliffe S, Feldman H, Gosling A.

J Am Acad Child Adolesc Psychiatry. 1992 May;31(3):455-61.

PMID:
1592777
15.

Prediction of response to methylphenidate among children with ADHD and mental retardation.

Handen BL, Janosky J, McAuliffe S, Breaux AM, Feldman H.

J Am Acad Child Adolesc Psychiatry. 1994 Oct;33(8):1185-93.

PMID:
7982869
16.

A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).

Swanson JM, Wigal SB, Wigal T, Sonuga-Barke E, Greenhill LL, Biederman J, Kollins S, Nguyen AS, DeCory HH, Hirshe Dirksen SJ, Hatch SJ; COMACS Study Group.

Pediatrics. 2004 Mar;113(3 Pt 1):e206-16.

PMID:
14993578
17.

Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder. Clinical efficacy and side-effects.

Buitelaar JK, van der Gaag RJ, Swaab-Barneveld H, Kuiper M.

J Child Psychol Psychiatry. 1996 Jul;37(5):587-95.

PMID:
8807439
18.

Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study.

Jain U, Hechtman L, Weiss M, Ahmed TS, Reiz JL, Donnelly GA, Harsanyi Z, Darke AC.

J Clin Psychiatry. 2007 Feb;68(2):268-77.

PMID:
17335326
19.

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder.

Rösler M, Fischer R, Ammer R, Ose C, Retz W.

Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):120-9. doi: 10.1007/s00406-008-0845-4. Epub 2009 Jan 22. Erratum in: Eur Arch Psychiatry Clin Neurosci. 2009 Sep;259(6):368.

PMID:
19165529
20.

Adverse side effects of methylphenidate among mentally retarded children with ADHD.

Handen BL, Feldman H, Gosling A, Breaux AM, McAuliffe S.

J Am Acad Child Adolesc Psychiatry. 1991 Mar;30(2):241-5.

PMID:
2016228
Items per page

Supplemental Content

Write to the Help Desk